Literature DB >> 21990280

Genetic basis of antibiotic resistance in pathogenic Acinetobacter species.

Laurent Poirel1, Rémy A Bonnin, Patrice Nordmann.   

Abstract

Antibiotic resistance in Acinetobacter spp., particularly Acinetobacter baumannii, is increasing rapidly. A. baumannii possesses two intrinsic β-lactamase genes, in addition to weak permeability and efflux systems, that together confer a natural reduced susceptibility to antibiotics. In addition, numerous acquired mechanisms of resistance have been identified in A. baumannii. The very high genetic plasticity of A. baumannii allows an accumulation of resistance determinants that give rise to multidrug resistance at an alarming rate. The role of novel genetic elements, such as resistance islands, in concentrating antibiotic resistance genes in A. baumannii requires detailed investigation in the near future.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21990280     DOI: 10.1002/iub.532

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  49 in total

1.  Co-production of AmpC and extended spectrum beta-lactamases in cephalosporin-resistant Acinetobacter baumannii in Egypt.

Authors:  Heba Shehta Said; Abdalbagi Basheer Benmahmod; Ramadan Hassan Ibrahim
Journal:  World J Microbiol Biotechnol       Date:  2018-12-03       Impact factor: 3.312

2.  Genetic features of the widespread plasmid coding for the carbapenemase OXA-48.

Authors:  Laurent Poirel; Rémy A Bonnin; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

3.  A Diverse Panel of Clinical Acinetobacter baumannii for Research and Development.

Authors:  Madeline R Galac; Erik Snesrud; Francois Lebreton; Jason Stam; Michael Julius; Ana C Ong; Rosslyn Maybank; Anthony R Jones; Yoon I Kwak; Kate Hinkle; Paige E Waterman; Emil P Lesho; Jason W Bennett; Patrick Mc Gann
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

4.  Multidrug-resistant plasmids repress chromosomally encoded T6SS to enable their dissemination.

Authors:  Gisela Di Venanzio; Ki Hwan Moon; Brent S Weber; Juvenal Lopez; Pek Man Ly; Robert F Potter; Gautam Dantas; Mario F Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-09       Impact factor: 11.205

5.  Genetic features of CTX-M-15-producing Acinetobacter baumannii from Haiti.

Authors:  Anaïs Potron; L Silvia Munoz-Price; Patrice Nordmann; Timothy Cleary; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

6.  OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Authors:  Paul G Higgins; Francisco J Pérez-Llarena; Esther Zander; Ana Fernández; Germán Bou; Harald Seifert
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

Review 7.  Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia.

Authors:  Li-Yang Hsu; Anucha Apisarnthanarak; Erum Khan; Nuntra Suwantarat; Abdul Ghafur; Paul Anantharajah Tambyah
Journal:  Clin Microbiol Rev       Date:  2016-10-19       Impact factor: 26.132

8.  Biochemical and genetic characterization of carbapenem-hydrolyzing β-lactamase OXA-229 from Acinetobacter bereziniae.

Authors:  Rémy A Bonnin; Alain A Ocampo-Sosa; Laurent Poirel; Hélène Guet-Revillet; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

9.  Copper Resistance of the Emerging Pathogen Acinetobacter baumannii.

Authors:  Caitlin L Williams; Heather M Neu; Jeremy J Gilbreath; Sarah L J Michel; Daniel V Zurawski; D Scott Merrell
Journal:  Appl Environ Microbiol       Date:  2016-09-30       Impact factor: 4.792

10.  Carbapenem resistance and acquired class D beta-lactamases in Acinetobacter baumannii from Croatia 2009-2010.

Authors:  M Vranić-Ladavac; B Bedenić; F Minandri; M Ištok; Z Bošnjak; S Frančula-Zaninović; R Ladavac; P Visca
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.